NNovo Nordisk Read More FDA warns Novo Nordisk about GLP-1 reporting violations2026-03-12 WASHINGTON — The Food and Drug Administration raised concerns about “serious violations” of its reporting requirements regarding potential side…
NNovo Nordisk Read More FDA warns Novo Nordisk about GLP-1 reporting violations2026-03-12 WASHINGTON — The Food and Drug Administration raised concerns about “serious violations” of its reporting requirements regarding potential side…
NNovo Nordisk Read More FDA warns Novo Nordisk about GLP-1 reporting violations2026-03-11 WASHINGTON — The Food and Drug Administration raised concerns about “serious violations” of its reporting requirements regarding potential side…